Ready to roll: how nationally funded innovations are taking the NHS by storm | Dr Liz Mear

Liz Mear

Dr Liz Mear, chief executive of the Innovation Agency, discusses a new national programme helping health and care providers overcome the barriers to adopting and spreading innovation.

Sometimes an offer seems too good to be true, and that may seem the case for a set of innovations being provided for free to health providers across England. But there’s no catch in this particular offer – four health products that will improve care for patients and reduce costs for providers. It’s through NHS England’s Innovation and Technology Payment (ITP) programme, which was launched earlier this year.

The ITP funds ‘real-world’ evaluation and covers the costs of four products to overcome financial barriers and encourage speedy uptake across the country. This follows hot on the heels of the Innovation and Technology Tariff (ITT) launched last year and live until next March – offering seven other innovations for free.

But of course, it’s not as simple as it sounds. We can’t simply ‘give away’ health technologies. There is effort involved in considering the new product and how it will impact on practice: will it require staff training or at least a level of buy-in?; changes in process or pathway?; hassle for the procurement and finance teams?

That’s where we come in, at the Innovation Agency and our fellow academic health science networks (AHSNs) around the country.

We know that even when new products are free, there are reasons why health and care providers struggle to introduce them. Some of these are outlined very clearly in the King’s Fund report Adoption and spread of innovation in the NHS, which draws lessons from eight innovations that have overcome obstacles to be successfully adopted in the NHS.

Our role at the Innovation Agency and the other AHSNs is to help trusts and commissioners overcome the barriers, using every lever at our disposal. We channel the latest national initiatives, funding opportunities and evidence of best practice through to our local stakeholders and help them to navigate an often confusing landscape.

This role has been given a huge boost with additional funding for AHSNs from the Office for Life Sciences, which is enabling us to provide a national network of Innovation Exchanges.

The idea is that we will offer a single gateway for innovators with proven products and systems, as well as a streamlined process for health and care professionals to articulate their needs and priorities. This will form a national information exchange of demand and supply to bring public and private sectors together to improve health and care.

As this work is already underway on a regional basis within AHSNs, the next step of creating a coordinated, single front door is a logical progression for us and we are excited about the opportunities it will bring for us and our partners – and for the patients and population who will benefit.

Watch out for more news on this in the coming months, and if you’re going to be at Expo next week, make sure visit the AHSN Network stand or come along to our pop-up university on the Innovation Exchange on day two.

In the meantime, do check out the products covered by the ITP:

  • HeartFlow: Advanced image analysis software that creates a 3D model of the coronary arteries and analyses the impact that blockages have on blood flow, to rapidly diagnose patients with suspected coronary artery disease.
  • Plus Sutures: A new type of surgical suture that reduces the rate of surgery-linked infections such as MRSA, through the use of antimicrobial suture packs.
  • Endocuff Vision: A new type of ‘bowel scope’ that improves colorectal examination for patients undergoing bowel cancer tests.
  • SecurAcath: A device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter.

You’ll find more information on each of these innovations at www.ahsnnetwork.com/innovation/innovation-technology-payment-itp

To support partners in our North West Coast region, we have established a Coaching Academy, delivering coaching in innovation implementation. We also have a Transformation team who work with our regional transformation partnerships and individual provider trusts to help them overcome any barriers, so they don’t miss out on great opportunities like this.

There is similar support provided by our 14 fellow AHSNs – we are all raring to go with this programme, so that patients receive the benefits of well proven innovations, as soon as possible.

If you are based in the North West Coast and would like more information, email info@innovationagencynwc.nhs.uk

For other regions, look up your local AHSN at: www.ahsnnetwork.com

Dr Liz Mear is chief executive of the Innovation Agency. Follow her and the AHSN Network on Twitter @MearLiz @AHSNNetwork

Latest Tweets

Latest Blog Post

Tackling medicines wastage through a scalable initiative | Diar Fattah

14 / 12 / 2018 12.08pm

With estimates exceeding £300 million wasted every year in the NHS on unused or partially used medicine, Diar Fattah, associate director of medicines optimisation at Dartford, Gravesham and Swanley (DGS) CCG, believes savings and efficiency opportunities around medicines wastage are ripe for the taking.

Why Register?

Great reasons to register with NHS Confederation

  • Access exclusive resources¬†
    Access member-only resources and tailor member benefits and services
  • Personalise your website
    Select topics of interest for recommended content
  • Comment and recommend
    Rate and share content with colleagues
  • Never miss a thing
    Register now to keep your finger on the pulse of the NHS Confederation

Log In

To book events and access member only content you need to register with us.  This only takes a moment via our registration page. If you have already registered login using your email address and password below.